Company intelligence / Profile preview

New Jersey Innovation Institute

Newark, New Jersey, United Statesnjii.com ↗

Ownership: Private
Employees: ~110
Development stage: Other

Overview

NJII has played a key role in fostering biotech/life science innovation in New Jersey. It launched BioCentriq—a CDMO for cell/gene therapies—later sold to GC corp. for $73M. It also co-leads the Merck Digital Sciences Studio accelerator supporting early-stage biopharma technology startups.

Industry: Academic Hospital/University/Research

Partnerships

Merck Digital Sciences Studio with Merck & Co., Merck Global Health Innovation Fund, Northpond Ventures, McKesson Ventures, Microsoft for Startups

Beyond the preview

Go deeper on New Jersey Innovation Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Jersey Innovation Institute.

Explore the full profile